Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprostadil Liposomes in Lower Extremity Arteriosclerosis Obliterans
NCT04197323Phase 2Unknown
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Oct 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vasostenoon in peripheral artery disease (PAD), sponsored by CSPC ZhongQi Pharmaceutical Technology. Status: unknown.
02
Drugs
Vasostenoon
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT04197323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04197323.